CapsuTech Overview

  • Founded
  • 2006
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

CapsuTech General Information

Description

Developer of new drug targeting entities designed to create nano-encapsulation of drugs. The company's new drug targeting entities deliver non-toxic drug molecules which provide improved stability and reduced drug degradation under exposure to light, heat, pH and protection against oxidation and enzymatic hydrolysis, enabling users to develop drugs, cosmetics, vitamins, food additives, proteins and cells.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
  • P.O. Box 1252
  • Nazareth Industrial Area
  • Nazareth Illit 17111
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CapsuTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Apr-2016 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view CapsuTech’s complete valuation and funding history, request access »

CapsuTech Patents

CapsuTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2692021-A1 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers Abandoned 28-Jun-2007 000000000
US-20100226987-A1 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers Abandoned 28-Jun-2007 000000000 0
EP-2170054-A2 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers Withdrawn 28-Jun-2007 000000000 0
EP-2170054-A4 Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers Withdrawn 28-Jun-2007 000000000 0
US-20080275139-A1 Peptides, polypeptides, oligonucleotides, polynucleotides or mixtures, covalently linked to starch hydrozylates, used for microencapsulation of drugs or cosmetics; time-release agents Abandoned 19-Dec-2005 A61Q19/00 0
To view CapsuTech’s complete patent history, request access »